KRAS inhibition is an effective therapy for appendiceal adenocarcinoma
- DOI
- 10.1186/s13045-026-01817-3
- Published
- 2026-07-02
- Container
- Journal of Hematology & Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-026-01817-3,
title = {KRAS inhibition is an effective therapy for appendiceal adenocarcinoma},
author = {Saikat Chowdhury and Ichiaki Ito and Vinay K. Pattalachinti and Abdelrahman M. G. Yousef and Mahmoud M. G. Yousef and Sacha El Khoury and Nicholas Hornstein and Ashlee Nichole Seldomridge and David Hong and Micheal J. Overman and Melissa W. Taggart and Wai Chin Foo and Beth Helmink and Keith F. Fournier and John Paul Shen},
year = {2026},
journal = {Journal of Hematology \& Oncology},
doi = {10.1186/s13045-026-01817-3},
url = {https://doi.org/10.1186/s13045-026-01817-3}
}RIS
TY - JOUR TI - KRAS inhibition is an effective therapy for appendiceal adenocarcinoma AU - Saikat Chowdhury AU - Ichiaki Ito AU - Vinay K. Pattalachinti AU - Abdelrahman M. G. Yousef AU - Mahmoud M. G. Yousef AU - Sacha El Khoury AU - Nicholas Hornstein AU - Ashlee Nichole Seldomridge AU - David Hong AU - Micheal J. Overman AU - Melissa W. Taggart AU - Wai Chin Foo AU - Beth Helmink AU - Keith F. Fournier AU - John Paul Shen PY - 2026 JO - Journal of Hematology & Oncology DO - 10.1186/s13045-026-01817-3 UR - https://doi.org/10.1186/s13045-026-01817-3 ER -
APA
Chowdhury, S., Ito, I., Pattalachinti, V. K., Yousef, A. M. G., Yousef, M. M. G., Khoury, S. E., Hornstein, N., Seldomridge, A. N., Hong, D., Overman, M. J., Taggart, M. W., Foo, W. C., Helmink, B., Fournier, K. F., & Shen, J. P. (2026). KRAS inhibition is an effective therapy for appendiceal adenocarcinoma. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-026-01817-3
Source records
- crossref · retrieved 2026-09-26T03:29:45.318Z